Dermatology Doctors in Allentown, PA Accepting Medicare

26 Dermatology doctors found. Showing 21 - 26

Richard W Mcclain, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1259 S Cedar Crest Blvd Ste 100, Allentown, PA 18103 Phone: 610-437-4134    Fax: 610-433-9690

Dr. Kristina Maureen Lim, DO Dermatology Medicare: Medicare Enrolled Practice Location: 1259 S Cedar Crest Blvd Ste 100, Allentown, PA 18103 Phone: 610-437-4134    Fax: 610-433-9690

Dr. Tanya Ermolovich, D.O. Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1259 S Cedar Crest Blvd Ste 100, Allentown, PA 18103 Phone: 610-437-4134    Fax: 610-433-9690

Claire Otteni Dorfman, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1259 S Cedar Crest Blvd, Suite 100, Allentown, PA 18103 Phone: 610-437-4134

Dr. Steven A Oberlender, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1259 S Cedar Crest Blvd Ste 100, Allentown, PA 18103 Phone: 610-437-4134    Fax: 610-433-9690

Veronica Rutt, DO Dermatology - MOHS-Micrographic Surgery Medicare: Medicare Enrolled Practice Location: 401 N 17th St Ste 311, Allentown, PA 18104 Phone: 610-969-4470

News Archive

Book on the most common interventional and therapeutic gastrointestinal endoscopic procedures

The aim of this book is to present a concise yet instructive overview of the most common interventional and therapeutic gastrointestinal endoscopic procedures. Although there exists a large amount of literature dealing with therapeutic endoscopy, this publication stands out for several reasons: To begin with, it has been written by a highly selected group of international experts who contribute their own tried and tested tips and tricks.

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

FDA accepts AVP-825 NDA for acute treatment of migraine

The U.S. Food and Drug Administration has accepted the New Drug Application (NDA) for AVP-825, an innovative closed-palate Breath Powered investigational drug-device combination product for the acute treatment of migraine.

Lexicon receives FDA Fast Track status for development of LX1033 for irritable bowel syndrome

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received "Fast Track" status from the U.S. Food and Drug Administration for the development of LX1033, an orally-delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome (IBS-d).

Read more Medical News

› Verified 6 days ago

• 1
• 2(current)